Erectile dysfunction drugs may help treat many other conditions

A new British Journal of Pharmacology review examines how phosphodiesterase-5 (PDE5) inhibitors, which were originally approved to treat erectile dysfunction, are finding clinical uses for a wide variety of conditions.

PDE5 inhibitors cause blood vessel dilation by targeting a particular cellular pathway that is involved in many normal physiological functions and in the pathophysiology of a wide range of diseases.

PDE5 inhibitors likely have effects on many organs and functions, and they have been approved to treat symptoms and . They are also being used off-label to treat conditions including diabetes and cancer.

Explore further

Viagra has the potential to be used as a treatment for rare cancers

More information: K-E Andersson, PDE5 Inhibitors - Pharmacology and Clinical Applications 20 Years After Sildenafil Discovery, British Journal of Pharmacology (2018). DOI: 10.1111/bph.14205
Journal information: British Journal of Pharmacology

Provided by Wiley
Citation: Erectile dysfunction drugs may help treat many other conditions (2018, April 19) retrieved 14 October 2019 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more